Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment ...Middle East

STOCKHOLM, April 8, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that the Company has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application no. 16/760,910...

Hence then, the article about calliditas receives notice of allowance for united states patent application covering setanaxib in cancer treatment was published today ( Monday 08/04/2024 - 10:29 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Calliditas receives notice of allowance for United States patent application covering setanaxib in cancer treatment )

Also on site :

• Macy’s Has a 12-Piece Lenox Scalloped Dinnerware Set for 59% Off That's Perfect for Hosting Spring Events
• This Spring, Divest From Clutter to Reclaim Personal Productivity Like a Boss .. PYMNTS.com
• This Can't Miss Scenic Spot Just Under an Hour from Vegas Will Have You Feeling Like You're in Another World